Anna Maria Barbui
- Epidemiology top 5%
- Hepatology top 2%
- Oncology top 10%
- Immunology
- Genetics
- Co-authors
- Mauro SalizzoniA FranchelloEzio DavidAlfredo MarzanoP PiantinoW. Debernardi‐VenonAlessia CiancioAntonina Smedile
- Topics
- Hepatitis B Virus Studies (6 papers)Hepatitis C virus research (6 papers)Cytomegalovirus and herpesvirus research (6 papers)
- Cited by
- HepatologyEpidemiologyOncology
- Journals
- BloodPLoS ONEJournal of Hepatology
- Partner nations
- ItalyNetherlandsUnited States
In The Last Decade
Anna Maria Barbui
25 papers receiving 751 citations
Peers
Comparison fields: 5 of 49
- Epidemiology 500
- Hepatology 428
- Oncology 234
- Immunology 130
- Genetics 87
Countries citing papers authored by Anna Maria Barbui
This map shows the geographic impact of Anna Maria Barbui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maria Barbui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maria Barbui more than expected).
Fields of papers citing papers by Anna Maria Barbui
This network shows the impact of papers produced by Anna Maria Barbui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maria Barbui. The network helps show where Anna Maria Barbui may publish in the future.
Co-authorship network of co-authors of Anna Maria Barbui
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Maria Barbui. A scholar is included among the top collaborators of Anna Maria Barbui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Maria Barbui. Anna Maria Barbui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Immunochemotherapy With Obinutuzumab Or Rituximab In Previously Untreated Follicular Lymphoma In The Randomized Phase III Gallium Study: Analysis By Chemotherapy Regimen | 1 |
| 3 | 17 | |
| 4 | 5 | |
| 5 | 11 | |
| 6 | 7 | |
| 7 | 19 | |
| 8 | 22 | |
| 9 | 45 | |
| 10 | Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. | 29 |
| 11 | TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS | 12 |
| 12 | 0 | |
| 13 | 1 | |
| 14 | 98 | |
| 15 | IgM antibodies against cytomegalovirus in SLE nephritis: viral infection or aspecific autoantibody? | 17 |
| 16 | 174 | |
| 17 | 122 | |
| 18 | 1 | |
| 19 | 5 | |
| 20 | 4 |
About Anna Maria Barbui
Anna Maria Barbui is a scholar working on Hepatology, Transplantation and Hematology, having authored 27 papers that have together received 782 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Cytomegalovirus and herpesvirus research (6 papers). The work is most often cited by research in Hepatology (428 citations), Epidemiology (500 citations) and Oncology (234 citations). Anna Maria Barbui has collaborated with scholars based in Italy, Netherlands and United States. Frequent co-authors include Mauro Salizzoni, A Franchello, Ezio David, Alfredo Marzano, P Piantino, W. Debernardi‐Venon, Alessia Ciancio, Antonina Smedile, Francesco Negro and E. Gentilcore. Their work appears in journals such as Blood, PLoS ONE and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.